Related Experiment Video
Updated: Aug 1, 2026
08:51
Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
Published on: November 11, 2022
1.4K
Mitigating Intraoperative Hypotension: A Review and Update on Recent Advances
Wael Saasouh1, Navid Manafi2, Asifa Manzoor2
1Department of Anesthesiology, Wayne State University School of Medicine, 42 West Warren Avenue, Detroit, MI 48201, USA; NorthStar Anesthesia, 6255 State Highway 161 #200, Irving, TX 75038, USA; Outcomes Research Consortium, Cleveland, OH, USA.
Advances in Anesthesia
|October 23, 2024
Summary
Intraoperative hypotension (IOH), common during surgery, can cause adverse outcomes. Management strategies are evolving, focusing on personalized care and predictive tools for better patient results.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Critical Care Medicine
Background:
- Intraoperative hypotension (IOH) frequently occurs during surgical procedures under anesthesia.
- IOH is associated with increased risks of postoperative adverse outcomes.
- Contributing factors include hypovolemia, vasodilation, impaired cardiac contractility, and patient comorbidities.
Purpose of the Study:
- To review current strategies for mitigating intraoperative hypotension.
- To highlight the importance of personalized approaches and technological advancements in managing IOH.
- To emphasize the need for considering patient-specific comorbidities in treatment decisions.
Main Methods:
- Literature review of recent research and technological advancements in IOH management.
- Analysis of factors contributing to IOH.
- Discussion of current and emerging mitigation strategies.
Main Results:
- IOH management strategies are continually evolving.
- Personalized blood pressure targets, pharmacologic interventions, and predictive analytics are key components.
- Effective IOH management requires a tailored approach considering individual patient comorbidities.
Conclusions:
- Optimizing intraoperative blood pressure is crucial for improving surgical outcomes.
- A multifaceted approach integrating personalized medicine and advanced tools is necessary for effective IOH management.
- Ongoing research and technological innovation are vital for advancing the care of patients experiencing IOH.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...